Yifei is a Staff Scientist working on the Wyss Institute’s Brain Targeting Program, which aims to develop brain shuttles to deliver therapeutics across the blood-brain barrier. His research interests are focused on nanomedicine-based drug delivery systems to address the obstacles in brain-related diseases, including brain tumor, and neurodegenerative diseases. Yifei received his Ph.D. in Pharmaceutical Science from Fudan University, China and recent postdoctoral training in the Brain Tumor Center of MD Anderson Cancer Center, Houston.